Azkka Pharmaceuticals Private Limited, a active private limited company, was established on 22 July 2016 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U36990GJ2016PTC093046. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹7.25 Cr and a paid-up capital of ₹6.62 Cr.
It upholds a compliant status. Employing 114 professional, Its leadership includes Malav Girishbhai Patel (Managing Director), Chirag Hasmukhbhai Patel (Managing Director), Vipinbhai Kantilal Patel (Director). Past directors included Malav Girishbhai Patel, Chirag Hasmukhbhai Patel, Hasmukhbhai Shivabhai Patel. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Mb House, 51, Chandrodaya Society, Opp. Golden Triangle, Stadium Road, Navr, Angpura,, Ahmedabad, Gujarat, 380014.
U36990GJ2016PTC093046
093046
22 July 2016
₹7.25 Cr
₹6.62 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Azkka Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Malav Girishbhai Patel | Managing Director | 22 Jul 2016 | Current |
| Chirag Hasmukhbhai Patel | Managing Director | 22 Jul 2016 | Current |
| Vipinbhai Kantilal Patel | Director | 20 Apr 2017 | Current |
| Aditya Vipinbhai Patel | Director | 20 Apr 2017 | Current |
| Mukti Sadhan Nath | Whole-Time Director | 11 May 2017 | Current |
| Girishbhai Manibhai Patel | Director | 20 Apr 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Apr 2017 | Past |
| Pramod Abcsdd | Director | 20 Apr 2017 | Past |
| Pramod Abcsdd | Director | 16 Jan 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Azkka Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.17% increase. The company also saw a substantial improvement in profitability, with a 80.98% increase in profit. The company's net worth dipped by a decrease of 1.77%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Azkka Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Azkka Pharmaceuticals has a workforce of 114 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Azkka Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Azkka Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Azkka Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Azkka Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
Progress on Mukti Sadhan Nath was appointed as a Whole-time director was appointed as a Whole-time director on 11 May 2017 & has been associated with this company since 8 years 6 months . was documented.
Bhavin Kaushik Bhatt was appointed as a Whole-time director was appointed as a Whole-time director on 11 May 2017 & has been associated with this company since 8 years 6 months . was recorded as a recent event.
Vipinbhai Kantilal Patel was appointed as a Director was appointed as a Director on 20 Apr 2017 & has been associated with this company since 8 years 7 months . was recorded as a recent event.
Aditya Vipinbhai Patel was appointed as a Director was appointed as a Director on 20 Apr 2017 & has been associated with this company since 8 years 7 months . was recorded as a recent event.
The CIN of Azkka Pharmaceuticals Private Limited is U36990GJ2016PTC093046.
Azkka Pharmaceuticals Private Limited is headquartered at Mb House, 51, Chandrodaya Society, Opp. Golden Triangle, Stadium Road, Navr, Angpura,, Ahmedabad, Gujarat, 380014.
Azkka Pharmaceuticals Private Limited was incorporated on 22 July 2016.
The current directors of Azkka Pharmaceuticals Private Limited are
The primary industry of Azkka Pharmaceuticals Private Limited is Manufacturing.
Azkka Pharmaceuticals Private Limited is unlisted.
The authorized capital of Azkka Pharmaceuticals Private Limited is ₹7.25 Cr, and the paid-up capital is ₹6.62 Cr.
The compliance status of Azkka Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX